VRCA

$4.95-5.89%

Verrica Pharmaceuticals Inc.

Market Cap

$87M

Sector

Materials

Industry

Pharmaceuticals

Beta

1.65

5yr monthly vs SPY

Price Chart

Loading…

Signals

Insider Velocity

Market & Alt Data

News

8

recent articles

Analyst Consensus

Strong Buy

13 analysts

Velocity Score

26.39x

Current Rate (90d)

469.22/mo

Baseline Rate

0.00/mo

Unique Buyers (90d)

4

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-08-18	2026-08-18	Kirby John J.	Interim CFO	Purchase	5,000	$4.93	$25K	24.0K	View
2026-08-18	2026-08-18	Rosenberg Noah L.	CMO	Purchase	2,030	$4.92	$10K	8,587	View
2026-08-17	2026-08-18	Rosenberg Noah L.	CMO	Purchase	4,200	$4.91	$21K	6,557	View
2026-08-17	2026-08-18	Rieger Jayson	Director & CEO and President	Purchase	5,000	$4.91	$25K	207.6K	View
2026-08-17	2026-08-18	Zawitz David	Chief Operating Officer	Purchase	6,000	$4.98	$30K	27.0K	View

1–5 of 6

1 / 2

Recent News

Verrica Pharmaceuticals to Present YCANTH® and VP-315 Data at Two Upcoming Dermatology Conferences

Yahoo Finance · 2026-09-10

Verrica Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Yahoo Finance · 2026-09-08

Verrica completes enrolment in Phase III trial of Ycanth

Yahoo Finance · 2026-08-28

Verrica Pharmaceuticals Announces Completion of Enrollment in First Pivotal Phase 3 Trial (COVE-2) Evaluating YCANTH® for the Treatment of Common Warts, with Topline Data Expected Q1 2027

Yahoo Finance · 2026-08-27

Informational purposes only, not investment advice.